EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice

Samuel Heuts iD, Angelique Ceulemans, Gerhardus J A J M Kuiper, Jan U Schreiber, Bernard J van Varik, Renske H Olie, Hugo Ten Cate, Jos G Maessen, Milan Milojevic iD, Bart Maesen iD

European Journal of Cardio-Thoracic Surgery · 04.10.2023 · 64 (4)

DOI: 10.1093/ejcts/ezad340 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 09.10.2023. Verfasst von Samuel Heuts und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Maastricht University Medical Centre+, Maastricht, Netherlands. Hauptthemen laut MEDLINE: Cardiac Surgical Procedures, Hemorrhage. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES Literature is scarce on the management of patients using direct oral anticoagulants (DOACs) undergoing elective, urgent and emergency surgery. Therefore, we summarize the current evidence and provide literature-based recommendations for the management of patients on DOACs in the perioperative phase. METHODS A general literature review was conducted on the pharmacology of DOACs and for recommendations on the management of cardiac surgical patients on DOACs. Additionally, we performed a systematic review for studies on the use of direct DOAC reversal agents in the emergency cardiac surgical setting. RESULTS When surgery is elective, the DOAC cessation strategy is relatively straightforward and should be adapted to the renal function. The same approach applies to urgent cases, but additional DOAC activity drug level monitoring tests may be useful. In emergency cases, idarucizumab can be safely administered to patients on dabigatran in any of the perioperative phases. However, andexanet alfa, which is not registered for perioperative use, should not be administered in the preoperative phase to reverse the effect of factor Xa inhibitors, as it may induce temporary heparin resistance. Finally, the administration of (activated) prothrombin complex concentrate may be considered in all patients on DOACs, and such concentrates are generally readily available. CONCLUSIONS DOACs offer several advantages over vitamin K antagonists, but care must be taken in patients undergoing cardiac surgery. Although elective and urgent cases can be managed relatively straightforwardly, the management of emergency cases requires particular attention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Surgical ProceduresHemorrhageHumansAdministration, OralAnticoagulantsDabigatranHeparin

Stichwörter der Autor:innen

AntidotesBleedingCardiac surgeryDirect oral anticoagulantsEmergency

Substanzen

AnticoagulantsDabigatranHeparin

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Maastricht University Medical Centre+, Maastricht, Netherlands.
  • Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, Netherlands.
  • Department of Neurology, Maastricht University Medical Centre+, Maastricht, Netherlands.
  • Department of Anaesthesiology and Pain Treatment, Maastricht University Medical Centre+, Maastricht, Netherlands.
  • Department of Internal Medicine, Gelre Ziekenhuizen, Apeldoorn, Netherlands.
  • Thrombosis Expertise Centre, Maastricht University Medical Centre+, Maastricht, Netherlands.

ORCID-Profile: Samuel Heuts, Milan Milojevic, Bart Maesen

Zitieren

APA

Heuts, S., Ceulemans, A., Kuiper, G. J. A. J. M., Schreiber, J. U., van Varik, B. J., Olie, R. H., Ten Cate, H., Maessen, J. G., Milojevic, M., & Maesen, B. (2023). Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice. European Journal of Cardio-Thoracic Surgery, 64(4). https://doi.org/10.1093/ejcts/ezad340

Vancouver

Heuts S, Ceulemans A, Kuiper GJAJM, Schreiber JU, van Varik BJ, Olie RH, et al. Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice. European Journal of Cardio-Thoracic Surgery. 2023;64(4). doi:10.1093/ejcts/ezad340

BibTeX
@article{Heuts2023,
  author = {Heuts, Samuel and Ceulemans, Angelique and Kuiper, Gerhardus J A J M and Schreiber, Jan U and van Varik, Bernard J and Olie, Renske H and Ten Cate, Hugo and Maessen, Jos G and Milojevic, Milan and Maesen, Bart},
  title = {Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2023},
  volume = {64},
  number = {4},
  doi = {10.1093/ejcts/ezad340}
}
Kostenlos starten →